Maxygen hands out pink slips

Maxygen is laying off 25 workers - 16% of its workforce - as it focuses more of its resources on clinical development and away from early-stage research. The Redwood City, CA-based company plans to ask the FDA next year for approval to start trials on two therapies - interferon alpha and GCSF.

- read this report from the San Francisco Business Times for more